Skip to content
SentinelMarket desk
Switch to dark mode

하스

450330KOSDAQView the 제약 sectorTheme Bio & healthcare

4,650KRWMarket close of 10/20 (Tue)

Down -1.69%-80KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)4,590KRWDown -1.29%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
4,730
High
4,730
Low
4,590
Day range
Day range low 4,590 high 4,730, open 4,730, close 4,650, previous close 4,730
Volume
0×10K shares
2.55 million KRW 0.05× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 3,790 to 7,800 won, 21% up from the low

21% of the way up from the lowest close in 1 year (252 sessions) · -40.4% from the high

Something to check

1 to check: operating loss

Free · no sign-inSource from 2021-05-17

Points to check

  • Earningsto check-798.43 million KRWOperating income over the last four quarters -798.43 million KRW (loss)Operating income, 8 quarters
  • Recent filingsnot verifiedOutside filing data coverage, so not verified
  • Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified

The other 3 are within the usual range

  • Daily move-1.69%usual range
  • Trading value0.1×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Quarterly results · Q2 2026

Source: DART financials (Q4 derived as annual − three quarters) · Amended filing reflected
  • Revenue4.1B KRWRevenue bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -10.6%
    vs. prior quarter
    +24.1%
  • Operating income-615.14 million KRWOperating income bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    Turned to loss
    vs. prior quarter
    Still a loss
  • Operating margin-14.9%Operating margin bars for the last 8 quarters; the dark bar is this quarter
    vs. year ago
    -35.8 pp
    vs. prior quarter
    +9.7 pp

Quarterly operating income trend

As of the latest official close · 2026-10-20Valuation filing date · 2026-08-13
2024Q2 107.94 million KRW2026Q2 -615.14 million KRWQ4 values are derived as the annual figure minus Q1–Q3. The value table marks them in the Type column.

Same sector · 제약

Down -1.68%

· 29 of 168 stocks up, preferred shares excluded · trading value 827.8B KRW

Same sector · top by trading value
Stock20DChangeTrading value
셀트리온Close over the last 20 sessions +11.4%Down -0.40%139.2B KRW
삼성바이오로직스Close over the last 20 sessions -1.3%Down -2.52%129.9B KRW
삼익제약Close over the last 20 sessions -20.4%Up +2.77%76.0B KRW
녹십자엠에스Close over the last 20 sessions +30.5%Up +6.67%55.6B KRW
유한양행Close over the last 20 sessions +11.5%Down -1.37%41.6B KRW

Schedule

  • Q3 report due · 11/16 (Mon) · in 25 days
  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.